We are live on ! Find out more
ANTX icon

AN2 Therapeutics
ANTX

36 hedge funds and large institutions have $72.4M invested in AN2 Therapeutics in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 5

100% more funds holding

Funds holding: 18 → 36 (+18)

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

0.61% more ownership

Funds ownership: 47.77% → 48.39% (+0.61%)

46% less capital invested

Capital invested by funds: $134M → $72.4M (-$61.7M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
36
Holders Change
+18
Holders Change %
+100%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
6
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.48M
2
DM
Deerfield Management
New York
+$1.75M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.43M
4
Citigroup
Citigroup
New York
+$1.16M
5
RCM
RA Capital Management
Massachusetts
+$1.08M

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$2.65M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.14M
3
Millennium Management
Millennium Management
New York
-$1.12M
4
CAC
Cowen and Company
New York
-$908K
5
WP
Woodline Partners
California
-$565K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$17K +$28.7K +2,171 New
Deutsche Bank
27
Deutsche Bank
Germany
$17K +$29.1K +2,196 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$15K +$26.3K +1,983 New
Bank of America
29
Bank of America
North Carolina
$13K +$21.7K +1,639 New
AB
30
Amalgamated Bank
New York
$11K +$18.5K +1,394 New
Legal & General Group
31
Legal & General Group
United Kingdom
$3K +$5.18K +391 New
Osaic Holdings
32
Osaic Holdings
Arizona
$2K +$2.65K +200 New
AIP
33
Ameritas Investment Partners
Nebraska
$2K +$4.61K +348 New
Wells Fargo
34
Wells Fargo
California
$1K +$967 +73 New
Millennium Management
35
Millennium Management
New York
– -$1.12M -74,238 Closed
CAC
36
Cowen and Company
New York
– -$908K -60,278 Closed
Goldman Sachs
37
Goldman Sachs
New York
– -$294K -19,497 Closed
Wellington Management Group
38
Wellington Management Group
Massachusetts
– -$250K -16,600 Closed
AFM
39
Anson Funds Management
Texas
– -$38K -2,500 Closed
CS
40
Credit Suisse
Switzerland
– +$26 +2 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– +$357 +27 New
1
2

ANTX Hedge Fund Activity: Q2 2022 in Review

36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in AN2 Therapeutics (ANTX) for Q2 2022, worth a combined $72.4M — down 46% from $134M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new ANTX positions and 5 closed out — a net gain of 18 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $2.48M. The largest seller was Monashee Investment Management, cutting an estimated $2.65M.

  • 36 institutional investors held AN2 Therapeutics (ANTX) as of Q2 2022, up from 18 in Q1 2022.
  • Funds reported $72.4M of AN2 Therapeutics stock for Q2 2022, down 46% quarter-over-quarter.
  • 23 funds opened new AN2 Therapeutics positions in Q2 2022 and 5 closed out, a net change of +18 holders.
  • The largest AN2 Therapeutics buyer in Q2 2022 was BlackRock, an estimated $2.48M added.
  • The largest AN2 Therapeutics seller in Q2 2022 was Monashee Investment Management, an estimated $2.65M sold.

Based on aggregated 13F filings for Q2 2022.